WHO ICTRP trial

To study the efficacy of strontium ranelate on the healing of surgically fixed…

ACTRN12611000876998 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12611000876998
Public title To study the efficacy of strontium ranelate on the healing of surgically fixed diaphyseal tibial fractures and compare it to placebo
Scientific title Efficacy of Strontium Ranelate versus placebo on time to fracture healing of tibial fractures in adults
Primary sponsor Pharmevo (Pvt.) Ltd.
Secondary sponsors The Indus Hospital
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Countries Pakistan
Conditions Fracture healing; Fracture healing;Injuries and Accidents - Fractures
Interventions The purpose of this study is to study the efficacy of strontium ranelate in the dose of 2gm daily on the healing of surgically fixed diaphyseal tibial fractures and compare it to placebo. The subjects will receive strontium ranelate for a…
Registration date Aug 17, 2011
Target size 100
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations